1. Home
  2. BXC vs THW Comparison

BXC vs THW Comparison

Compare BXC & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bluelinx Holdings Inc.

BXC

Bluelinx Holdings Inc.

HOLD

Current Price

$48.62

Market Cap

458.5M

ML Signal

HOLD

THW

abrdn World Healthcare Fund Shares of Beneficial Interest

HOLD

Current Price

$12.63

Market Cap

513.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BXC
THW
Founded
2004
N/A
Country
United States
United States
Employees
1700
N/A
Industry
Wholesale Distributors
Finance Companies
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
458.5M
513.9M
IPO Year
2004
2015

Fundamental Metrics

Financial Performance
Metric
BXC
THW
Price
$48.62
$12.63
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$71.50
N/A
AVG Volume (30 Days)
69.0K
87.0K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
N/A
N/A
Revenue This Year
$5.04
N/A
Revenue Next Year
$5.09
N/A
P/E Ratio
$2,602.75
N/A
Revenue Growth
N/A
N/A
52 Week Low
$44.78
$10.10
52 Week High
$88.30
$13.19

Technical Indicators

Market Signals
Indicator
BXC
THW
Relative Strength Index (RSI) 34.03 56.67
Support Level $44.78 $12.33
Resistance Level $74.73 $12.78
Average True Range (ATR) 2.82 0.23
MACD -0.63 0.02
Stochastic Oscillator 9.16 74.71

Price Performance

Historical Comparison
BXC
THW

About BXC Bluelinx Holdings Inc.

BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh, and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.

About THW abrdn World Healthcare Fund Shares of Beneficial Interest

Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.

Share on Social Networks: